Drug discovery is breaking under its own weight. Biopharma spends over $250 billion a year on R&D, yet new medicines still take 10+ years and $2.6 billion to reach patients and 90% of clinical candidates fail. Scientists wait an average of 60 days between experiments, buried under fragmented data and analyses that can’t be reproduced. Every delay means a patient waits longer and a timeline slips by years. Mithrl is the Scientific Decision Engine (SDE) that accelerates the discovery loop for biopharma and other R&D teams. With Mithrl’s enterprise- ready agentic SDE, purpose-built for scientific rigor, bench scientists and computational biologists move from raw data to reproducible insights and defensible IP opportunities faster than ever before.

Learn More